Dual azithromycin/ceftriaxone therapy for gonorrhea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold

Research output: Contribution to journalLetter

Original languageEnglish
JournalJournal of Infectious Diseases
Volume224
Issue number9
Pages (from-to)1623-1624
Number of pages2
ISSN0022-1899
DOIs
Publication statusPublished - 2021

Cite this